The treatment of stages I-IV favorable histology Wilms' tumor

Journal of Clinical Oncology

Volumn 22, Issue 8, 2004, Pages 1366-1372

  Green, Daniel M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOLOGY; HUMAN; MEDICAL SOCIETY; NEPHRECTOMY; NEPHROBLASTOMA; NOTE; PRIORITY JOURNAL; PROGNOSIS; UNITED KINGDOM; ARTICLE; FOLLOW UP; INFANT; KIDNEY TUMOR; METASTASIS; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; FOLLOW-UP STUDIES; HUMANS; INFANT; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; WILMS TUMOR;

EID: 2342635849     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.08.008     Document Type: Note

References (28)

1. D'Angio GJ, Evans AE, Breslow N, et al: The treatment of Wilms' tumor: Results of the National Wilms' Tumor Study. Cancer 38:633-646, 1976
2. D'Angio GJ, Evans AE, Breslow, et al: The treatment of Wilms' tumor: Results of the Second National Wilms' Tumor Study. Cancer 47:2302-2311, 1981
3. D'Angio GJ, Breslow N, Beckwith JB, et al: Treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study. Cancer 64:349-360, 1989
4. Pritchard J, Imeson J, Barnes J, et al: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) first Wilms' tumor study (UKW - 1). J Clin Oncol 13:124-133, 1995
5. Garcia M, Douglass C, Schlosser JV: Classification and prognosis in Wilms' tumor. Radiology 80:574-580, 1963
6. Breslow NE, Palmer NF, Hill LR, et al: Wilms' tumor: Prognostic factors for patients without metastases at diagnosis. Cancer 41:1577-1589, 1978
7. Green DM, Breslow NE, Beckwith JB, et al: Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: A report from the National Wilms' Tumor Study. J Clin Oncol 11:91-95, 1993
8. Green DM, Breslow NE, Beckwith JB, et al: Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor. A report from the National Wilms Tumor Study Group. J Clin Oncol 19:3719-3724, 2001
9. Green DM: Diagnosis and Management of Malignant Solid Tumors in Infants and Children. Hingham, MA, Martinus Nijhoff Publishing, 1985, p 148
10. Tournade MF, Com-Hougue C, Voute PA, et al: Results of the sixth International Society of Pediatric Oncology Wilms tumor trial and study: A risk-adapted therapeutic approach in Wilms tumor. J Clin Oncol 11:1014-1023, 1993
11. Breslow NE, Takashima JR, Whitton JA, et al: Second malignant neoplasms following treatment for Wilms tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 13:1851-1859, 1995
12. Green DM, Zevon MA, Reese PA, et al: Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 22:1-10, 1994
13. Neglia JP, Friedman DL, Yasui Y, et al: Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618-629, 2001
14. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
15. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
16. Lipshultz S, Lipsitz S, Sallan S, et al: Chronic progressive left ventricular systolic dysfunction and afterload excess years after doxorubicin therapy for acute lymphoblastic leukemia. Proc Am Soc Clin Oncol 19:580a, 2000 (abstr 2281)
17. Sorensen K, Levitt G, Bull C, et al: Anthracycline dose in childhood acute lymphoblastic leukemia: Issues of early survival versus late toxicity. J Clin Oncol 15:61-68, 1997
18. Bristow MR, Mason JW, Billingham ME, et al: Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88:168-175, 1978
19. Green DM, Grigoriev YA, Nan B, et al: Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 19:1926-1934, 2001
20. Mertens AC, Yasui Y, Neglia JP, et al: Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 19:3163-3172, 2001
21. Green DM, Hyland A, Chung CS, et al: Cancer and cardiac mortality among fifteen-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 17:3207-3215, 1999
22. Green DM, Evans I, Moksness J, et al: The treatment of children with stage IV Wilms tumor. A report from the National Wilms Tumor Study Group. Med Pediatr Oncol 26:147-152, 1996
23. Green DM, Finkelstein JZ, Tefft M, et al: Diffuse interstitial pneumonitis after pulmonary irradiation for metastatic Wilms' tumor. A report from the National Wilms' Tumor Study. Cancer 63:450-453, 1989
24. Mitchell C, Morris Jones P, Kelsey A, et al: The treatment of Wilms' tumour: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. Br J Cancer 83:602-608, 2000
25. De Kraker J, Lemerle J, Voute PA, et al: Wilms' tumor with pulmonary metastases at diagnoses: The significance of primary chemotherapy. J Clin Oncol 8:1187-1190, 1990
26. Green DM: Wilms' tumor. Eur J Cancer 33:409-418, 1997
27. Lemerle J, Voute PA, Tournade MF, et al: Effectiveness of preoperative chemotherapy in Wilms' tumor: Results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1:604-609, 1983
28. Tournade MF, Com-Hougue C, De Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the ninth International Society of Pediatric Oncology Wilms tumor trial and study: J Clin Oncol 19:488-500, 2001